Jacobi Capital Management’s PTC Therapeutics PTCT Stock Holding History

Jacobi Capital Management’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,400	Closed	-$52K	–	1091
2021 Q3	$52K	Hold	1,400	–	–	0.01%	646
2021 Q2	$59K	Hold	1,400	–	–	0.01%	590
2021 Q1	$66K	Hold	1,400	–	–	0.01%	518
2020 Q4	$85K	Hold	1,400	–	–	0.01%	437
2020 Q3	$65K	Hold	1,400	–	–	0.01%	446
2020 Q2	$71K	Hold	1,400	–	–	0.01%	411
2020 Q1	$62K	Hold	1,400	–	–	0.01%	394
2019 Q4	$67K	Buy	+1,400	New	+$59.5K	0.01%	421
2016 Q4	–	Sell	-3,000	Closed	-$40K	–	679
2016 Q3	$40K	Hold	3,000	–	–	0.02%	275
2016 Q2	$21K	Buy	+3,000	New	+$22K	0.01%	342

Other funds holding PTCT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jacobi Capital Management's PTCT Position: Q4 2021 in Review

Jacobi Capital Management sold out of PTC Therapeutics (PTCT) in Q4 2021, closing a stake of 1,400 shares — an estimated $52K sold.

Jacobi Capital Management first reported a position in PTCT in Q2 2016 and held it in 10 quarters. The position peaked at $85K in Q4 2020. 178 funds tracked by Wall St. Rank hold PTCT as of Q4 2021.

Jacobi Capital Management reported no remaining PTC Therapeutics position as of Q4 2021 after selling out during the quarter.
Jacobi Capital Management sold 1,400 PTC Therapeutics shares in Q4 2021, an estimated $52K.
Jacobi Capital Management first reported a position in PTC Therapeutics in Q2 2016 and held it in 10 quarters.
Jacobi Capital Management's PTC Therapeutics position peaked at $85K in Q4 2020.
178 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2021.

Based on Jacobi Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.